Vigilância de eventos adversos pós-vacinação e segurança de programas de imunização: [revisão]

Waldman, Eliseu Alves; Luhm, Karin Regina; Monteiro, Sandra Aparecida Moreira Gomes; Freitas, Fabiana Ramos Martin de.
Rev. saúde pública ; 45(1): 173-184, Feb. 2011.
Artigo em Português | LILACS | ID: lil-569467

Documentos relacionados

  1. Revisiting study design and methodology for pathogen reduced platelet transfusions: a round table discussion.
  2. Chia, a large annotated corpus of clinical trial eligibility criteria.
  3. Implementation of patient-reported outcome measures in real-world evidence studies: Analysis of ClinicalTrials.gov records (1999-2021).
  4. The Fate of FDA Postapproval Studies.
  5. Phase IV non-inferiority trials and additional claims of benefit.
  6. [Gene therapy for vision restoration in patients with Leber congenital amaurosis (LCA) due to RPE65 gene mutations: beginning the phase IV trial].
  7. Opicapone for the treatment of Parkinson's disease: a review.
  8. Discontinuation and nonpublication of clinical trials in orthopaedic oncology.
  9. Comment on 'Dupilumab significantly improves sleep in adults with atopic dermatitis: results from the 12-week placebo-controlled period of the 24-week phase IV randomized double-blinded placebo-controlled DUPISTAD study'.
  10. [Non-interventional post-authorisation studies in Spain: impact of the 2002 regulation].